How many email patterns does Calypso Biotech use?

Calypso Biotech uses 1 known email pattern.

What domain does Calypso Biotech use for work emails?

Calypso Biotech uses calypsobiotech.com for work email addresses.

Most Common Email Formats at Calypso Biotech

The most accurate and popular Calypso Biotech's email format is First.Last@calypsobiotech.com (ex. John.Doe@calypsobiotech.com). Calypso Biotech also uses as email structures. Calypso Biotech uses up to 1 different email patterns.

Calypso Biotech Email Formats	Example	Percentage
First.Last@calypsobiotech.com	John.Doe@calypsobiotech.com	100%

Calypso Biotech Email Formats

Example

Percentage

First.Last@calypsobiotech.com

John.Doe@calypsobiotech.com

100%

Frequently Asked Questions

What does Calypso Biotech do?

Calypso Biotech was founded in 2013. The company's main headquarters is located in 102 Gustav Mahlerpelin Amsterdam, North Holland Netherlandsoperates in the Pharmaceutical Manufacturing industry, along with similar companies like OWKINMevion Medical SystemsIntrasense. You can visit calypsobiotech.com. Explore Calypso Biotech's company overview page for more information.

What is Calypso Biotech's email address format?

Calypso Biotech's email format typically follows the pattern of First.Last@calypsobiotech.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Calypso Biotech have currently?

Calypso Biotech has approximately 11 employees as of April 2026. Key team members to contact include Chief Executive Officer And Founder: A. V.. For more team information and contact data, explore Calypso Biotech's employee directory with LeadIQ.

Calypso Biotech Email Format

Pharmaceutical ManufacturingNorth Holland, Netherlands11-50 Employees

Calypso Biotech, based in Amsterdam, North Holland, Netherlands, is a biopharmaceutical company that focuses on discovering and developing therapies for autoimmune diseases. Its core approach centers on therapeutic antibodies as a primary modality to address conditions within this area. In 2021, the company expanded its leadership by appointing Jos G.A. Houbiers as Chief Medical Officer and adding Ena Prosser to its board. 

One of its programs involves CALY-001, a fully human monoclonal antibody targeting MMP-9, developed under a global licensing and collaboration arrangement with EA Pharma Co., Ltd. Calypso Biotech operates within the pharmaceutical manufacturing sector as a developer of antibody-based therapies for autoimmune diseases. The organization maintains a relatively small team, reflecting a focused research and development operation.

Most Common Email Formats at Calypso Biotech

Frequently Asked Questions

What does Calypso Biotech do?

What is Calypso Biotech's email address format?

How many employees does Calypso Biotech have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Calypso Biotech Email Format

Verify Calypso Biotech email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Calypso Biotech

Frequently Asked Questions

What does Calypso Biotech do?

What is Calypso Biotech's email address format?

How many employees does Calypso Biotech have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Calypso Biotech Email Format

Verify Calypso Biotech email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.